Hero image

Research & products

We run to, not from, the world’s biggest health challenges.

The journey to discovery is guided by science – and inspired by patients

We use the power of leading-edge science to save and improve lives around the world. The path to discovery is often unclear, but we are tireless in seeking solutions for some of the world’s most difficult health challenges.

Our work in numbers

~17.5K

people employed in research and development

285M

people reached through our major programs and partnerships

$12.2B

invested in R&D in 2021

We address the world’s most difficult health challenges, following leading-edge science

Hero_RGB_Discovery-Blue
Discovery & development

Step inside Merck Research Laboratories (MRL) where our quest to save and improve lives through research and development begins

B5 - Our pipeline__
Pipeline

We’re focused on inventing new medicines and vaccines to help more people

B5 we work to deliver
Products

Our focus on breakthrough science is working

Clinical trials

Our progress is due in large part to the important and tough scientific questions we set out to answer with our trials and collaborations. We are grateful to the thousands of volunteers who participate in our clinical trials – making this all possible.

Father playing with young son at breakfast table

Our commitment to patients is unwavering

As long as there are still patients in hospitals, doctors and nurses desperate to add years to the lives of their patients, and a world where treatments aren’t accessible to all, we will be here, fighting with all we have to deliver more, sooner.

Discovery starts here

Our scientists are applying the latest groundbreaking research technologies and revolutionizing how we discover and develop medicines and vaccines

View our stories

New podcast: The power of one pipeline

Through business development and licensing, Merck Research Laboratories stays primed for new opportunities and partnerships to drive our innovation

Read more

Next: New podcast: The power of one pipeline

How our OneTen pilot program paved the way for hiring diverse talent

Our Durham, N.C. site became one of the first Merck locations to adopt the OneTen initiative, with the goal of closing the wealth gap for Black Americans

Read more

Next: How our OneTen pilot program paved the way for hiring diverse talent

Merck’s Q1 2022 earnings report

Merck’s (NYSE: MRK) Q1 2022 results reflect sustained strong business momentum with robust top and bottom- line growth. The company announced Q1 worldwide sales of $15.9 billion, an increase of 50% from Q1 2021. “We successfully delivered across our key strategic priorities and achieved strong top and bottom-line growth,” said chief executive officer and president, Robert […]

Read more

Next: Merck’s Q1 2022 earnings report

The Vaccine Pioneers

Scientists who made giant strides in the fight against viral diseases and vaccine history

Read more

Next: The Vaccine Pioneers

Vaccines: Our history, our legacy

Merck and its legacy companies have been working to discover and develop vaccines for more than a century

Read more

Next: Vaccines: Our history, our legacy

New podcast: The power of one pipeline

Through business development and licensing, Merck Research Laboratories stays primed for new opportunities and partnerships to drive our innovation

Read more

Next: New podcast: The power of one pipeline

How our OneTen pilot program paved the way for hiring diverse talent

Our Durham, N.C. site became one of the first Merck locations to adopt the OneTen initiative, with the goal of closing the wealth gap for Black Americans

Read more

Next: How our OneTen pilot program paved the way for hiring diverse talent

Merck’s Q1 2022 earnings report

Merck’s (NYSE: MRK) Q1 2022 results reflect sustained strong business momentum with robust top and bottom- line growth. The company announced Q1 worldwide sales of $15.9 billion, an increase of 50% from Q1 2021. “We successfully delivered across our key strategic priorities and achieved strong top and bottom-line growth,” said chief executive officer and president, Robert […]

Read more

Next: Merck’s Q1 2022 earnings report

The Vaccine Pioneers

Scientists who made giant strides in the fight against viral diseases and vaccine history

Read more

Next: The Vaccine Pioneers

Vaccines: Our history, our legacy

Merck and its legacy companies have been working to discover and develop vaccines for more than a century

Read more

Next: Vaccines: Our history, our legacy

Previous
Next
a cow with a blue sky background

Protecting animal health

Our Animal Health business is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them.